Observational Study on Safety and Efficacy in Subjects Using NovoMix 70 [Insulin aspart/insulin protamine aspart] (Biphasic Insulin Aspart) for Treatment of Type 2 Diabetes Mellitus.
Phase of Trial: Phase IV
Latest Information Update: 09 Aug 2014
At a glance
- Drugs Insulin aspart/insulin protamine aspart (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions
- Acronyms INTENSIV
- Sponsors Novo Nordisk
- 31 Aug 2018 Biomarkers information updated
- 15 Oct 2009 Actual end date changed from 581 to 590 as reported by ClinicalTrials.gov.
- 06 Nov 2008 Actual patient number (581) added as reported by ClinicalTrials.gov.